Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,177 | -3,528 | -2,729 | -1,753 | -1,429 |
| Accounts receivable | 1,000 | -444 | 456 | 31 | -25 |
| Accounts payable and accrued liabilities | -51 | 118 | 90 | 72 | 93 |
| Other Working Capital | 1,943 | -227 | 648 | 54 | 347 |
| Other Operating Activity | -891 | 767 | -200 | 125 | 46 |
| Operating Cash Flow | $-1,176 | $-3,314 | $-1,735 | $-1,471 | $-968 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -66 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-66 | $N/A | $0 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 825 | 3,322 | 3,071 | 1,245 | 1,375 |
| Financing Cash Flow | $825 | $3,322 | $3,071 | $1,245 | $1,375 |
| Beginning Cash Position | 3,240 | 3,232 | 3,232 | 3,232 | 3,232 |
| End Cash Position | 2,823 | 3,240 | 4,568 | 3,006 | 3,639 |
| Net Cash Flow | $-417 | $8 | $1,336 | $-226 | $407 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,176 | -3,314 | -1,735 | -1,471 | -968 |
| Capital Expenditure | -66 | N/A | N/A | N/A | 0 |
| Free Cash Flow | -1,242 | -3,314 | -1,735 | -1,471 | -968 |